Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $376,535 - $438,738
1,171 Added 7.95%
15,907 $5.82 Million
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $757,506 - $863,257
2,555 Added 20.98%
14,736 $4.77 Million
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $809,153 - $950,064
2,903 Added 31.29%
12,181 $3.95 Million
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $817,659 - $1.02 Million
-3,484 Reduced 27.3%
9,278 $2.66 Million
Q4 2021

Jan 28, 2022

BUY
$224.85 - $279.04 $85,892 - $106,593
382 Added 3.09%
12,762 $3.53 Million
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $130,965 - $161,171
591 Added 5.01%
12,380 $2.86 Million
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $45,318 - $58,618
251 Added 2.18%
11,789 $2.71 Million
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $122,089 - $158,050
743 Added 6.88%
11,538 $2.16 Million
Q4 2020

Feb 11, 2021

BUY
$130.46 - $172.63 $67,056 - $88,731
514 Added 5.0%
10,795 $1.82 Million
Q3 2020

Nov 04, 2020

BUY
$146.22 - $169.13 $57,756 - $66,806
395 Added 4.0%
10,281 $1.52 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $156,064 - $187,821
1,144 Added 13.09%
9,886 $1.62 Million
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $13,452 - $16,650
-113 Reduced 1.28%
8,742 $1.21 Million
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $91,416 - $113,227
855 Added 10.69%
8,855 $1.3 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $19,756 - $21,489
185 Added 2.37%
8,000 $895,000
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $502,875 - $586,983
4,539 Added 138.55%
7,815 $866,000
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $24,933 - $29,348
-224 Reduced 6.4%
3,276 $425,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $4,871 - $5,457
-46 Reduced 1.3%
3,500 $405,000
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $15,368 - $19,208
179 Added 5.32%
3,546 $381,000
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $6,964 - $7,992
-92 Reduced 2.66%
3,367 $0
Q1 2018

May 04, 2018

BUY
$74.21 - $87.6 $5,639 - $6,657
76 Added 2.25%
3,459 $268,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $8,275 - $8,876
101 Added 3.08%
3,383 $286,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $6,242 - $6,928
81 Added 2.53%
3,282 $281,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,201
3,201 $263,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Argi Investment Services, LLC Portfolio

Follow Argi Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argi Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argi Investment Services, LLC with notifications on news.